Literature DB >> 24028765

Influence of nutritional deficiency on prognosis of renal cell carcinoma (RCC).

Kyungtae Ko1, Young H Park, Jeong W Lee, Ja H Ku, Cheol Kwak, Hyeon H Kim.   

Abstract

OBJECTIVE: To evaluate the prognosis of patients with renal cell carcinoma (RCC) by nutritional status defined by body mass index (BMI), serum albumin and cholesterol. PATIENTS AND METHODS: This study retrospectively enrolled 1437 patients who underwent radical nephrectomy (932) or partial nephrectomy (505) for RCC. We assigned nutritional status according to the presence of none or one nutritional risk factor (control group) and two or all three of the following nutritional risk factors (nutritional deficiency group). The nutritional factors and thresholds were preoperative albumin level (<3.5 g/dL), preoperative cholesterol level (<220 mg/dL), and preoperative BMI (<23 kg/m(2) )
RESULTS: The patients' mean (sd) age was 55.23 (12.41) years and BMI was 24.36 (3.17) kg/m(2) . The mean (sd) serum cholesterol level was 180.07 (38.24) mg/dL, and the albumin level was 4.2 (0.45) g/dL. In all, 141 (9.8%) patients had none of the nutritional deficiency criteria, 802 (55.8%) had one, 429 (29.9%) had two, and 65 (4.5%) had all three. Clinicopathological variables, i.e. female gender, high tumour stage, positive lymph node metastasis, positive distant metastasis, high nuclear grade and non-clear cell type histopathology were associated with the nutritional deficiency group. In multivariate Cox analysis, nutritional deficiency was an independent predictor for RCC recurrence (hazard ratio [HR] 1.39, 95% confidence interval [CI] 1.05-1.83, P = 0.020) and RCC-related mortality (HR 2.06, 95% CI 1.39-3.03, P < 0.001).
CONCLUSION: Nutritional deficiency defined by BMI, serum albumin and cholesterol is an important factor that predicts postoperative prognosis of patients with RCC who have undergone radical or partial nephrectomy.
© 2013 The Authors. BJU International © 2013 BJU International.

Entities:  

Keywords:  albumin; body mass index; cholesterol; nutritional status; prognosis; renal cell carcinoma

Mesh:

Year:  2013        PMID: 24028765     DOI: 10.1111/bju.12275

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  14 in total

1.  The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinoma.

Authors:  Ho Won Kang; Sung Min Kim; Won Tae Kim; Seok Joong Yun; Sang-Cheol Lee; Wun-Jae Kim; Eu Chang Hwang; Seok Ho Kang; Sung-Hoo Hong; Jinsoo Chung; Tae Gyun Kwon; Hyeon Hoe Kim; Cheol Kwak; Seok-Soo Byun; Yong-June Kim
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-12       Impact factor: 4.553

2.  Geriatric Nutrition Risk Index is an Important Predictor of Cancer-Specific Survival, but not Recurrence-Free Survival, in Patients Undergoing Surgical Resection for Non-Metastatic Renal Cell Carcinoma.

Authors:  Hideaki Miyake; Hiromoto Tei; Masato Fujisawa
Journal:  Curr Urol       Date:  2017-03-30

3.  Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinoma.

Authors:  Ho Won Kang; Sung Pil Seo; Won Tae Kim; Seok Joong Yun; Sang-Cheol Lee; Wun-Jae Kim; Eu Chang Hwang; Seok Ho Kang; Sung-Hoo Hong; Jinsoo Chung; Tae Gyun Kwon; Hyeon Hoe Kim; Cheol Kwak; Seok-Soo Byun; Yong-June Kim
Journal:  Int J Clin Oncol       Date:  2017-08-08       Impact factor: 3.402

4.  Prognostic significance of preoperative Naples prognostic score on short- and long-term outcomes after pancreatoduodenectomy for ampullary carcinoma.

Authors:  Jikuan Jin; Hebin Wang; Feng Peng; Xiaoxiang Wang; Min Wang; Feng Zhu; Guangbing Xiong; Renyi Qin
Journal:  Hepatobiliary Surg Nutr       Date:  2021-12       Impact factor: 7.293

5.  Predicting Overall Survival Using Preoperative Nutritional and Inflammation Status for Colorectal Cancer.

Authors:  Tamuro Hayama; Tsuyoshi Ozawa; Mitsuo Tsukamoto; Yoshihisa Fukushima; Ryu Shimada; Keijiro Nozawa; Keiji Matsuda; Shoichi Fujii; Takeo Fukagawa; Yojiro Hashiguchi
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

6.  Impact of the Preoperative Controlling Nutritional Status (CONUT) Score on the Survival after Curative Surgery for Colorectal Cancer.

Authors:  Yasuhito Iseki; Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Hiroshi Ohtani; Kenji Sugano; Tetsuro Ikeya; Kazuya Muguruma; Hiroaki Tanaka; Takahiro Toyokawa; Katsunobu Sakurai; Kosei Hirakawa
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

7.  Nutritional screening is strongly associated with overall survival in patients treated with targeted agents for metastatic renal cell carcinoma.

Authors:  Weijie Gu; Guiming Zhang; Lijiang Sun; Qi Ma; Yue Cheng; Hailiang Zhang; Guohai Shi; Yao Zhu; Dingwei Ye
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-04-20       Impact factor: 12.910

8.  Hypertriglyceridemia is a potential preoperative predictor for biochemical recurrence after radical prostatectomy.

Authors:  Minyong Kang; Chang Wook Jeong; Ja Hyeon Ku; Choel Kwak; Hyeon Hoe Kim
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

9.  The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.

Authors:  Takahiro Toyokawa; Naoshi Kubo; Tatsuro Tamura; Katsunobu Sakurai; Ryosuke Amano; Hiroaki Tanaka; Kazuya Muguruma; Masakazu Yashiro; Kosei Hirakawa; Masaichi Ohira
Journal:  BMC Cancer       Date:  2016-09-06       Impact factor: 4.430

10.  Circulating Concentrations of Vitamin B6 and Kidney Cancer Prognosis: A Prospective Case-Cohort Study.

Authors:  David C Muller; Mattias Johansson; David Zaridze; Anush Moukeria; Vladimir Janout; Ivana Holcatova; Marie Navratilova; Dana Mates; Øivind Midttun; Per Magne Ueland; Paul Brennan; Ghislaine Scelo
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.